Figure 1:
![(A–C) Three axial 68Ga-DOTATATE PET dynamic images (first, fourth, and ninth 5-minute frame) in a 66-year-old woman in group A with a history of World Health Organization grade II meningioma status after resection 4 months prior to imaging and (D–F) corresponding PET T1-weighted post-gadolinium-enhancement fusion images from 5-minute frames at (A, D) 10 minutes after injection, (B, E) 30 minutes after injection, and (C, F) 45 minutes after injection. (G) Corresponding reference tissue (superior sagittal sinus [SSS]) and targeted tissue (meningioma) region time-activity curves (TACs). DOTATATE = tetraazacyclododecane tetraacetic acid octreotate, 68Ga = gallium 68, p.i. = postinjection.](https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=8965533_rycan.210067.fig1.jpg)
(A–C) Three axial 68Ga-DOTATATE PET dynamic images (first, fourth, and ninth 5-minute frame) in a 66-year-old woman in group A with a history of World Health Organization grade II meningioma status after resection 4 months prior to imaging and (D–F) corresponding PET T1-weighted post-gadolinium-enhancement fusion images from 5-minute frames at (A, D) 10 minutes after injection, (B, E) 30 minutes after injection, and (C, F) 45 minutes after injection. (G) Corresponding reference tissue (superior sagittal sinus [SSS]) and targeted tissue (meningioma) region time-activity curves (TACs). DOTATATE = tetraazacyclododecane tetraacetic acid octreotate, 68Ga = gallium 68, p.i. = postinjection.